We are live on ! Find out more
UTHR icon

United Therapeutics
UTHR

383 hedge funds and large institutions have $8.87B invested in United Therapeutics in 2015 Q2 according to their latest regulatory filings, with 70 funds opening new positions, 132 increasing their positions, 138 reducing their positions, and 49 closing their positions.

New
Increased
Maintained
Reduced
Closed

62% more call options, than puts

Call options by funds: $64.9M | Put options by funds: $40M

43% more first-time investments, than exits

New positions opened: 70 | Existing positions closed: 49

5% more funds holding

Funds holding: 366 → 383 (+17)

2% less capital invested

Capital invested by funds: $9.02B → $8.87B (-$146M)

4% less repeat investments, than reductions

Existing positions increased: 132 | Existing positions reduced: 138

33% less funds holding in top 10

Funds holding in top 10: 15 → 10 (-5)

Holders
383
Holders Change
+17
Holders Change %
+4.64%
% of All Funds
10.32%
Holding in Top 10
10
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-33.33%
% of All Funds
0.27%
New
70
Increased
132
Reduced
138
Closed
49
Calls
$64.9M
Puts
$40M
Net Calls
+$24.9M
Net Calls Change
-$9.86M

Top Buyers

Rank Fund Capital Flow
1
PI
Putnam Investments
Massachusetts
+$92.2M
2
Renaissance Technologies
Renaissance Technologies
New York
+$65.7M
3
Deutsche Bank
Deutsche Bank
Germany
+$59M
4
Invesco
Invesco
Georgia
+$57.9M
5
First Trust Advisors
First Trust Advisors
Illinois
+$56.4M

Top Sellers

Rank Fund Capital Flow
1
TCM
TimesSquare Capital Management
New York
-$140M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$134M
3
LSV Asset Management
LSV Asset Management
Illinois
-$116M
4
YCMGA
York Capital Management Global Advisors
New York
-$64.2M
5
CCM
Consonance Capital Management
New York
-$58.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
DC
401
Deere & Company
Illinois
– -$2.05M -11,898 Closed
HIP
402
Hatteras Investment Partners
North Carolina
– -$1.87M -10,828 Closed
Creative Planning
403
Creative Planning
Kansas
– -$1.61M -9,343 Closed
JG
404
Jefferies Group
New York
– -$1.59M -9,196 Closed
NIT
405
NumerixS Investment Technologies
British Columbia, Canada
– -$1.09M -6,300 Closed
MCM
406
Moore Capital Management
New York
– -$1.03M -6,000 Closed
GMIM
407
General Motors Investment Management
New York
– -$864K -5,009 Closed
LCM
408
Landscape Capital Management
New Jersey
– -$862K -5,000 Closed
GA
409
Geneva Advisors
Illinois
– -$848K -4,920 Closed
NG
410
NatWest Group
United Kingdom
– -$838K -4,857 Closed
Verition Fund Management
411
Verition Fund Management
Connecticut
– -$586K -3,399 Closed
LI
412
LMCG Investments
Massachusetts
– -$552K -3,199 Closed
UFF
413
USA Financial Formulas
Michigan
– -$546K -3,167 Closed
CIM
414
Calvert Investment Management
Maryland
– -$364K -2,110 Closed
JIP
415
Jaffetilchin Investment Partners
Florida
– -$363K -2,104 Closed
HIM
416
Hillsdale Investment Management
Ontario, Canada
– -$362K -2,100 Closed
NV
417
Nair Vinay
– -$352K -2,042 Closed
ACM
418
Ativo Capital Management
Illinois
– -$328K -1,900 Closed
CMBA
419
C.M. Bidwell & Associates
Hawaii
– -$320K -1,855 Closed
HEIP
420
Hudson Edge Investment Partners
New Jersey
– -$314K -1,821 Closed
PA
421
Perceptive Advisors
New York
– -$255K -1,481 Closed
ST
422
Spot Trading
Illinois
– -$235K -1,362 Closed
QCMC
423
Quantum Capital Management (California)
California
– -$213K -1,245 Closed
SGH
424
Schonfeld Group Holdings
New York
– -$207K -1,200 Closed
ST
425
Smithfield Trust
Pennsylvania
– -$100K -578 Closed
14 15 16
17
18

UTHR Hedge Fund Activity: Q2 2015 in Review

383 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in United Therapeutics (UTHR) for Q2 2015, worth a combined $8.87B — down 1.6% from $9.02B a quarter earlier.

Buyers outnumbered sellers: 70 funds opened new UTHR positions and 49 closed out — a net gain of 21 holders — while 132 added to existing stakes and 138 trimmed.

The largest buyer was Putnam Investments, adding an estimated $92.2M. The largest seller was TimesSquare Capital Management, cutting an estimated $140M.

  • 383 institutional investors held United Therapeutics (UTHR) as of Q2 2015, up from 366 in Q1 2015.
  • Funds reported $8.87B of United Therapeutics stock for Q2 2015, down 1.6% quarter-over-quarter.
  • 70 funds opened new United Therapeutics positions in Q2 2015 and 49 closed out, a net change of +21 holders.
  • The largest United Therapeutics buyer in Q2 2015 was Putnam Investments, an estimated $92.2M added.
  • The largest United Therapeutics seller in Q2 2015 was TimesSquare Capital Management, an estimated $140M sold.

Based on aggregated 13F filings for Q2 2015.